Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H15Cl3N2OS.HNO3 |
Molecular Weight | 500.783 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O[N+]([O-])=O.ClC1=CC(Cl)=C(C=C1)C(CN2C=CN=C2)OCC3=CSC4=C3C=CC=C4Cl
InChI
InChIKey=HAAITRDZHUANGT-UHFFFAOYSA-N
InChI=1S/C20H15Cl3N2OS.HNO3/c21-14-4-5-16(18(23)8-14)19(9-25-7-6-24-12-25)26-10-13-11-27-20-15(13)2-1-3-17(20)22;2-1(3)4/h1-8,11-12,19H,9-10H2;(H,2,3,4)
DescriptionCurator's Comment: description was created based on several sources, including:
http://www.rxlist.com/ertaczo-drug.htm
https://www.drugs.com/mtm/sertaconazole-topical.html
http://www.wikidoc.org/index.php/Sertaconazole
Curator's Comment: description was created based on several sources, including:
http://www.rxlist.com/ertaczo-drug.htm
https://www.drugs.com/mtm/sertaconazole-topical.html
http://www.wikidoc.org/index.php/Sertaconazole
Sertaconazole is a azole antifungal that is FDA approved for the treatment of interdigital tinea pedis in immunocompetent patients 12 years of age and older, caused by: Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum. Sertaconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Common adverse reactions include contact dermatitis, dry skin, burning skin and application site skin tenderness.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1780 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | ERTACZO Approved UseERTACZO® (sertaconazole nitrate) Cream, 2%, is indicated for the topical treatment of interdigital tinea pedis in immunocompetent patients 12 years of age and older, caused by: Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum (see CLINICAL STUDIES Section). Launch Date2003 |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1.79 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/19889586 |
300 mg single, vaginal dose: 300 mg route of administration: Vaginal experiment type: SINGLE co-administered: |
SERTACONAZOLE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
43.31 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/19889586 |
300 mg single, vaginal dose: 300 mg route of administration: Vaginal experiment type: SINGLE co-administered: |
SERTACONAZOLE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
20.25 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/19889586 |
300 mg single, vaginal dose: 300 mg route of administration: Vaginal experiment type: SINGLE co-administered: |
SERTACONAZOLE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE food status: UNKNOWN |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1% |
SERTACONAZOLE plasma | Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
Sample Use Guides
Cream should be applied to the affected and immediate surrounding area(s) twice daily for 4 weeks.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9395851
MIC for Candida parapsilosis (0.26 mg/l) demonstrated a higher activity of sertaconazole against this species, in contrast to Candida tropicalis (MIC 1.49 mg/l). Against dermatophytes, MIC for sertaconazole was MIC 0.41 mg/l and against Cryptococcus neoformans yeasts - arithmetic mean MIC 1.24 mg/l.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
236601
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | RxNorm | ||
|
1DV05410M5
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | |||
|
DBSALT001382
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | |||
|
DTXSID2045529
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | |||
|
C47716
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | |||
|
200103
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | |||
|
SUB04374MIG
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | |||
|
1DV05410M5
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | |||
|
m9874
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | Merck Index | ||
|
99592-39-9
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | |||
|
83687
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | |||
|
100000084931
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201196
Created by
admin on Fri Dec 15 15:32:24 GMT 2023 , Edited by admin on Fri Dec 15 15:32:24 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD